Serum Fetuin A, hs-CRP and Homocysteine as Biochemical Markers of Cardiovascular Complications in Chronic Dialysis Patients.

Simple item page
dc.contributor.authorPerihan, H Tawfi k
dc.contributor.authorSawsan, S Hafez
dc.contributor.authorNermine, H Mahmoud
dc.contributor.authorHesham, M E l Sayed
dc.date.accessioned2015-08-19T08:23:24Z
dc.date.available2015-08-19T08:23:24Z
dc.date.issued2015-01
dc.description.abstractIntroduction: Chronic kidney disease (CKD) patients are considered a high risk group of cardiovascular disease in which vascular calcifi cation plays central role. A pivotal role in the inhibition of calcifi cation is played by fetuin-A. Th e measurement of infl ammatory markers such as high sensitivity C-reactive protein (hs-CRP) and homocysteine which promotes atherosclerosis is helpful in predicting cardiovascular disease in ESRD patients on regular dialysis. Material and Method: Th e study included 40 adult CKD patients divided into 30 ESRD patients on conventional hemodialysis, 15 with CVD and 15 without CVD, as well as 10 CKD patients on conservative treatment. Ten healthy subjects served as a control group. Enzyme-linked immunosorbent assays were used for fetuin-A, hs-CRP and homocysteine. Results: ESRD patients showed a signifi cant increase in serum hs-CRP, homocysteine and decrease in fetuin-A compared to control group. In addition, ESRD patients with CVD and without CVD showed a signifi cant increase in hs-CRP, homocysteine and only those with CVD had signifi cantly decreased fetuin-A in relation to CKD patients. Th e study revealed increased levels of hs-CRP and decrease in fetuin-A in ESRD patients with CVD compared to ESRD patients without CVD. Fetuin-A showed a negative correlation with hs-CRP and homocysteine in ESRD patients with and without CVD. Conclusion: Th e combined use of hs-CRP at a cutoff of (10 mg/dL) with either fetuin-A at a cutoff value of (0.26 g/L) or alternatively with homocysteine at a cutoff value of (48.23 μmol/L) proved to be eff ective for discrimination of CVD patients from other ESRD or CKD patients.en_US
dc.identifier.citationTawfi k Perihan H, Hafez Sawsan S, Mahmoud Nermine H, Sayed Hesham M E l. Serum Fetuin A, hs-CRP and Homocysteine as Biochemical Markers of Cardiovascular Complications in Chronic Dialysis Patients. Acta Medica International. 2015 Jan-Jun: 2(1): 57-64.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/162082
dc.language.isoenen_US
dc.source.urihttps://www.actamedicainternational.com/Article.aspx?id=46&volume=2&issue=1&type=1en_US
dc.subjectChronic kidney diseaseen_US
dc.subjectC-reactive proteinen_US
dc.subjectFetuin-Aen_US
dc.subjectHomocysteineen_US
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshBiological Markers
dc.subject.meshC-Reactive Protein --blood
dc.subject.meshFemale
dc.subject.meshCardiovascular Diseases --diagnosis
dc.subject.meshCardiovascular Diseases --epidemiology
dc.subject.meshCardiovascular Diseases --diseases
dc.subject.meshHomocysteine --blood
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshRenal Dialysis --adverse effects
dc.subject.meshRenal Insufficiency, Chronic --blood
dc.subject.meshRenal Insufficiency, Chronic --complications
dc.subject.meshYoung Adult
dc.subject.meshalpha-Fetoproteins --blood
dc.titleSerum Fetuin A, hs-CRP and Homocysteine as Biochemical Markers of Cardiovascular Complications in Chronic Dialysis Patients.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ami2015v2n1p57.pdf
Size:
671.12 KB
Format:
Adobe Portable Document Format
Description:
Journal artical
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Acta Medica International